Table 4 Sites of distant metastases (at time of first diagnosis and at longer follow-up) in 75 patients. The site of metastases was documented in 37 of 49 patients, with 1–3 sites per patient (total of 54 sites)

From: Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

Site

Number of patients

% of patients/sites

95% confidence interval for patients (%)

Lung and pleura

18

24/33

15–35

Brain

13

17/24

10–28

Lymph nodes

7

9/13

4–18

Liver

6

8/11

3–17

Skeleton

4

5/7

1–13

Skin

3

4/6

0.8–11

Adrenal glands

2

3/4

0.3–9

Peritoneal carcinoma

1

1/2

0.03–7